Annual EBIT
$224.00 M
-$123.20 M-35.48%
December 31, 2023
Summary
- As of February 20, 2025, ACA annual earnings before interest & taxes is $224.00 million, with the most recent change of -$123.20 million (-35.48%) on December 31, 2023.
- During the last 3 years, ACA annual EBIT has risen by +$75.20 million (+50.54%).
- ACA annual EBIT is now -35.48% below its all-time high of $347.20 million, reached on December 31, 2022.
Performance
ACA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$34.90 M
-$29.70 M-45.98%
September 30, 2024
Summary
- As of February 20, 2025, ACA quarterly earnings before interest & taxes is $34.90 million, with the most recent change of -$29.70 million (-45.98%) on September 30, 2024.
- Over the past year, ACA quarterly EBIT has dropped by -$14.80 million (-29.78%).
- ACA quarterly EBIT is now -83.17% below its all-time high of $207.40 million, reached on December 31, 2022.
Performance
ACA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$198.80 M
-$14.80 M-6.93%
September 30, 2024
Summary
- As of February 20, 2025, ACA TTM earnings before interest & taxes is $198.80 million, with the most recent change of -$14.80 million (-6.93%) on September 30, 2024.
- Over the past year, ACA TTM EBIT has dropped by -$188.90 million (-48.72%).
- ACA TTM EBIT is now -49.08% below its all-time high of $390.40 million, reached on March 31, 2023.
Performance
ACA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ACA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.5% | -29.8% | -48.7% |
| 3 y3 years | +50.5% | -6.7% | +90.4% |
| 5 y5 years | +133.6% | -19.8% | +29.4% |
ACA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.5% | +109.3% | -83.2% | +123.7% | -49.1% | +85.8% |
| 5 y | 5-year | -35.5% | +109.3% | -83.2% | +168.5% | -49.1% | +90.4% |
| alltime | all time | -35.5% | +133.6% | -83.2% | +428.8% | -49.1% | +491.7% |
Arcosa EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $34.90 M(-46.0%) | $198.80 M(-6.9%) |
| Jun 2024 | - | $64.60 M(+16.2%) | $213.60 M(+5.4%) |
| Mar 2024 | - | $55.60 M(+27.2%) | $202.60 M(-9.6%) |
| Dec 2023 | $224.00 M(-35.5%) | $43.70 M(-12.1%) | $224.00 M(-42.2%) |
| Sep 2023 | - | $49.70 M(-7.3%) | $387.70 M(+0.1%) |
| Jun 2023 | - | $53.60 M(-30.4%) | $387.20 M(-0.8%) |
| Mar 2023 | - | $77.00 M(-62.9%) | $390.40 M(+12.4%) |
| Dec 2022 | $347.20 M(+224.5%) | $207.40 M(+321.5%) | $347.20 M(+123.4%) |
| Sep 2022 | - | $49.20 M(-13.4%) | $155.40 M(+8.2%) |
| Jun 2022 | - | $56.80 M(+68.0%) | $143.60 M(+21.3%) |
| Mar 2022 | - | $33.80 M(+116.7%) | $118.40 M(+10.7%) |
| Dec 2021 | $107.00 M(-28.1%) | $15.60 M(-58.3%) | $107.00 M(+2.5%) |
| Sep 2021 | - | $37.40 M(+18.4%) | $104.40 M(-4.7%) |
| Jun 2021 | - | $31.60 M(+41.1%) | $109.60 M(-12.9%) |
| Mar 2021 | - | $22.40 M(+72.3%) | $125.90 M(-15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $148.80 M(-3.1%) | $13.00 M(-69.5%) | $148.80 M(-10.4%) |
| Sep 2020 | - | $42.60 M(-11.1%) | $166.00 M(-0.5%) |
| Jun 2020 | - | $47.90 M(+5.7%) | $166.90 M(+3.4%) |
| Mar 2020 | - | $45.30 M(+50.0%) | $161.40 M(+5.1%) |
| Dec 2019 | $153.60 M(+60.2%) | $30.20 M(-30.6%) | $153.60 M(+0.3%) |
| Sep 2019 | - | $43.50 M(+2.6%) | $153.10 M(+31.8%) |
| Jun 2019 | - | $42.40 M(+13.1%) | $116.20 M(+12.6%) |
| Mar 2019 | - | $37.50 M(+26.3%) | $103.20 M(+7.6%) |
| Dec 2018 | $95.90 M(-26.3%) | $29.70 M(+350.0%) | $95.90 M(+9.4%) |
| Sep 2018 | - | $6.60 M(-77.6%) | $87.70 M(-23.5%) |
| Jun 2018 | - | $29.40 M(-2.6%) | $114.70 M(+34.5%) |
| Mar 2018 | - | $30.20 M(+40.5%) | $85.30 M(+54.8%) |
| Dec 2017 | $130.10 M(-34.0%) | $21.50 M(-36.0%) | $55.10 M(+64.0%) |
| Sep 2017 | - | $33.60 M | $33.60 M |
| Dec 2016 | $197.20 M(-10.2%) | - | - |
| Dec 2015 | $219.60 M | - | - |
FAQ
- What is Arcosa annual earnings before interest & taxes?
- What is the all time high annual EBIT for Arcosa?
- What is Arcosa annual EBIT year-on-year change?
- What is Arcosa quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Arcosa?
- What is Arcosa quarterly EBIT year-on-year change?
- What is Arcosa TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Arcosa?
- What is Arcosa TTM EBIT year-on-year change?
What is Arcosa annual earnings before interest & taxes?
The current annual EBIT of ACA is $224.00 M
What is the all time high annual EBIT for Arcosa?
Arcosa all-time high annual earnings before interest & taxes is $347.20 M
What is Arcosa annual EBIT year-on-year change?
Over the past year, ACA annual earnings before interest & taxes has changed by -$123.20 M (-35.48%)
What is Arcosa quarterly earnings before interest & taxes?
The current quarterly EBIT of ACA is $34.90 M
What is the all time high quarterly EBIT for Arcosa?
Arcosa all-time high quarterly earnings before interest & taxes is $207.40 M
What is Arcosa quarterly EBIT year-on-year change?
Over the past year, ACA quarterly earnings before interest & taxes has changed by -$14.80 M (-29.78%)
What is Arcosa TTM earnings before interest & taxes?
The current TTM EBIT of ACA is $198.80 M
What is the all time high TTM EBIT for Arcosa?
Arcosa all-time high TTM earnings before interest & taxes is $390.40 M
What is Arcosa TTM EBIT year-on-year change?
Over the past year, ACA TTM earnings before interest & taxes has changed by -$188.90 M (-48.72%)